Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 1, 2013, Pages 31-36

  Hernández Romero, Diana ^a,c   Marín, Francisco ^a,c   Roldán, Vanessa ^b,c   Peñafiel, Pablo ^a,c   Vilchez, Juan Antonio ^a,c   Orenes Piñero, Esteban ^a,c   Giner, José Antonio ^a   Valdés, Mariano ^a,c   García Alberola, Arcadio ^a,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

^c IMIB   (Spain)

Author keywords

biomarkers; crioablation; flutter; myocardial remodeling; necrosis; RF ablation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATINE KINASE MB; GELATINASE A; GELATINASE B; PROCOLLAGEN C PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TROPONIN; TROPONIN T;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOABLATION; DIABETES MELLITUS; FEMALE; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART VENTRICLE REMODELING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; MALE; RADIOFREQUENCY ABLATION; SMOKING;

AGED; BIOLOGICAL MARKERS; CATHETER ABLATION; CRYOSURGERY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MYOCARDIAL STUNNING; MYOCARDIUM; NECROSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84872190245     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12017     Document Type: Article

References (15)

1. Hindricks G, and on behalf of the Multicentre European Radiofrequency Survey (MERFS). Investigators of the Working Group on Arrhythmias of the European Society of Cardiology. The Multicentre European Radiofrequency Survey (MERFS): Complications of radiofrequency catheter ablation of arrhythmias. Eur Heart J 1993; 14: 1644-1653.
2. Nakagawa H, Lazzara R, Khastgir T, Beckman KJ, McClelland JH, Imai S, Pitha JV, et al. Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter. Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation 1996; 94: 407-424.
3. Poty H, Saoudi N, Abdel Azia A, Nair M, Letac B,. Radiofrequency catheter ablation of type 1 atrial flutter. Prediction of late success by electrophysiological criteria. Circulation 1995; 92: 1398-1392.
4. Hirose H, Kato K, Suzuki O, Yoshida T, Oguri M, Yajima K, Yokoi T,. Diagnostic accuracy of cardiac markers for myocardial damage after radiofrequency catheter ablation. J Interv Card Electrophysiol 2006; 16: 169-174.
5. Katritsis D, Hossein-Nia M, Anastasakis A, Poloniecki I, Holt DW, Camm AJ, Ward DE, et al. Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J 1997; 18: 1007-1013.
6. Madrid AH, Del Rey JM, Rubi J, Ortega J, Gonzalez Rebollo JM, Seara JG, Ripio E, et al. Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: Approach to size of necrosis. Am Heart J 1998; 136: 948-955.
7. Manolis AS, Vassilikos V, Maounis T, Melita-Manolis H, Psarros L, Haliasos A, Cokkinos DV,. Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: Procedural correlates. J Am College Cardiol 1999; 34: 1099-1105.
8. Brueckmann M, Wolpert C, Bertsch T, Sueseibeck T, Liebetrau C, Kaden JJ, Huhle G, et al. Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2004; 15: 686-691.
9. Haines DE, Whayne JG, Walker J, Nath S, Bruns DE,. The effect of radiofrequency catheter ablation on myocardial creatine kinase activity. J Cardiovasc Electrophysiol 1995; 6: 79-88.
10. Katritsis DG, Hossein-Nia M, Anastasakis A, Poloniecki J, Holt DW, Camm AJ, Ward DE, et al. Myocardial injury induced by radiofrequency and low energy ablation: A quantitative study of CK isoforms, CK-MB, and troponin-T concentrations. Pacing Clin Electrophysiol 1998; 21: 1410-1416.
11. Bednarek J, Tomala I, Majewski J, Szczepkowski J, Lelakowski J,. Biochemical markers of myocardial damage after radiofrequency ablation. Kardiologia Polska 2004; 60: 335-341.
12. Oswald H, Gardiwal A, Lissel Ch, Yu H, Klein G,. Difference in humoral biomarkers for myocardial injury and inflammation in radiofrequency ablation versus cryoablation. Pacing Clin Electrophysiol 2007; 30: 885-890.
13. Carlsson J, Erdogan A, Guettler N, Schulte B, Lay D, Neuzner J, Hamm CW, et al. Myocardial injury during radiofrequency catheter ablation: Comparison of focal and linear lesions. Pacing Clin Electrophysiol 2001; 24: 962-968.
14. Grubman E, Pavri BB, Lyle S, Reynolds C, Denofrio D, Kocovic DZ,. Histopathologic effects of radiofrequency catheter ablation in previously infarcted human myocardium. J Cardiovasc Electrophysiol 1999; 10: 336-342.
15. Wojcik M, Janin S, Kuniss M, Berkowitsch A, Erkapic D, Zaltsberg S, Madlener K, et al. Limitations of biomarkers serum levels during pulmonary vein isolation. Rev Esp Cardiol 2011; 64: 127-32.